{"id":"https://openalex.org/W64322893","doi":"https://doi.org/10.1176/ajp.148.6.714","title":"Benzodiazepines in the treatment of schizophrenia: a review and reappraisal","display_name":"Benzodiazepines in the treatment of schizophrenia: a review and reappraisal","alternate_titles":[],"publication_year":1991,"publication_date":"1991-06-01","ids":{"openalex":"https://openalex.org/W64322893","doi":"https://doi.org/10.1176/ajp.148.6.714","mag":"64322893","pmid":"https://pubmed.ncbi.nlm.nih.gov/1674645"},"language":"en","primary_location":{"id":"doi:10.1176/ajp.148.6.714","doi":"https://doi.org/10.1176/ajp.148.6.714","is_oa":false,"landing_page_url":"https://doi.org/10.1176/ajp.148.6.714","pdf_url":null,"source":{"id":"https://openalex.org/S116025658","display_name":"American Journal of Psychiatry","issn_l":"0002-953X","issn":["0002-953X","1535-7228"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316602","host_organization_name":"American Psychiatric Association","host_organization_lineage":["https://openalex.org/P4310316602"],"host_organization_lineage_names":["American Psychiatric Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W64322893"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036257304","display_name":"Owen M. Wolkowitz","orcid":"https://orcid.org/0000-0003-0655-5042","observed_orcids":["https://orcid.org/0000-0003-0655-5042"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"O M Wolkowitz","raw_affiliation_strings":["Department of Psychiatry, University of California, School of Medicine, San Francisco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, University of California, School of Medicine, San Francisco","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113481449","display_name":"D. Pickar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D Pickar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.4353,"has_fulltext":false,"cited_by_count":237,"citation_normalized_percentile":{"value":0.90510949,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"148","issue":"6","first_page":"714","last_page":"726"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12308","display_name":"Mental Health and Psychiatry","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1211","display_name":"Philosophy"},"field":{"id":"https://openalex.org/fields/12","display_name":"Arts and Humanities"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/benzodiazepines","display_name":"benzodiazepines","score":1.0},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9760000109672546},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.8709999918937683},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.9700000286102295},{"id":"https://openalex.org/keywords/antipsychotic-effects","display_name":"antipsychotic effects","score":0.8769999742507935},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.621999979019165},{"id":"https://openalex.org/keywords/treatment-response-variability","display_name":"treatment response variability","score":0.796999990940094},{"id":"https://openalex.org/keywords/dopamine","display_name":"dopamine","score":0.5189999938011169},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.8830000162124634}],"concepts":[{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.7977810502052307},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.6803209185600281},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.5793971419334412},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.5463665723800659},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4986870288848877},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4798569083213806},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4693884253501892},{"id":"https://openalex.org/C3017459112","wikidata":"https://www.wikidata.org/wiki/Q162657","display_name":"Neurotransmitter systems","level":3,"score":0.4386245608329773},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4355425238609314},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.23830237984657288},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.21525907516479492},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14505326747894287},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012565","descriptor_name":"Schizophrenic Psychology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1176/ajp.148.6.714","doi":"https://doi.org/10.1176/ajp.148.6.714","is_oa":false,"landing_page_url":"https://doi.org/10.1176/ajp.148.6.714","pdf_url":null,"source":{"id":"https://openalex.org/S116025658","display_name":"American Journal of Psychiatry","issn_l":"0002-953X","issn":["0002-953X","1535-7228"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316602","host_organization_name":"American Psychiatric Association","host_organization_lineage":["https://openalex.org/P4310316602"],"host_organization_lineage_names":["American Psychiatric Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Psychiatry","raw_type":"journal-article"},{"id":"pmid:1674645","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1674645","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of psychiatry","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.476.4330","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.476.4330","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.pn.psychiatryonline.org/data/Journals/AJP/3556/714.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"}],"awards":[{"id":"https://openalex.org/G8044005323","display_name":"ALPRAZOLAM - NEUROLEPTIC TREATMENT IN SCHIZOPHRENIA","funder_award_id":"R29MH043612","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":86,"referenced_works":["https://openalex.org/W156720073","https://openalex.org/W172090877","https://openalex.org/W190233593","https://openalex.org/W616322675","https://openalex.org/W1562782196","https://openalex.org/W1934525866","https://openalex.org/W1963755391","https://openalex.org/W1969290878","https://openalex.org/W1972023082","https://openalex.org/W1974541129","https://openalex.org/W1974796539","https://openalex.org/W1976813310","https://openalex.org/W1979285858","https://openalex.org/W1993408357","https://openalex.org/W1996017952","https://openalex.org/W1998691527","https://openalex.org/W1998922007","https://openalex.org/W1999235777","https://openalex.org/W1999412138","https://openalex.org/W2001242871","https://openalex.org/W2002430564","https://openalex.org/W2007911341","https://openalex.org/W2008743172","https://openalex.org/W2014645124","https://openalex.org/W2019052063","https://openalex.org/W2021231778","https://openalex.org/W2024258285","https://openalex.org/W2031212745","https://openalex.org/W2037740307","https://openalex.org/W2037782390","https://openalex.org/W2042806906","https://openalex.org/W2052273656","https://openalex.org/W2066883358","https://openalex.org/W2067370714","https://openalex.org/W2067884699","https://openalex.org/W2069601329","https://openalex.org/W2072031818","https://openalex.org/W2074614877","https://openalex.org/W2078065500","https://openalex.org/W2080254657","https://openalex.org/W2085958346","https://openalex.org/W2086866139","https://openalex.org/W2087955936","https://openalex.org/W2090560116","https://openalex.org/W2090937361","https://openalex.org/W2093422116","https://openalex.org/W2095133554","https://openalex.org/W2097798815","https://openalex.org/W2099894730","https://openalex.org/W2106113808","https://openalex.org/W2112999607","https://openalex.org/W2120514141","https://openalex.org/W2126954121","https://openalex.org/W2127776863","https://openalex.org/W2134787905","https://openalex.org/W2145243651","https://openalex.org/W2163145678","https://openalex.org/W2165477398","https://openalex.org/W2176159411","https://openalex.org/W2214040524","https://openalex.org/W2337842195","https://openalex.org/W2342182932","https://openalex.org/W2394818808","https://openalex.org/W2401431511","https://openalex.org/W2405692750","https://openalex.org/W2406048726","https://openalex.org/W2410162781","https://openalex.org/W2411707926","https://openalex.org/W2411924610","https://openalex.org/W2412320762","https://openalex.org/W2415898186","https://openalex.org/W2417291072","https://openalex.org/W2417944685","https://openalex.org/W2419452315","https://openalex.org/W2419505425","https://openalex.org/W2430222721","https://openalex.org/W2433769285","https://openalex.org/W2435079311","https://openalex.org/W2461758200","https://openalex.org/W2471794574","https://openalex.org/W2474666704","https://openalex.org/W4238413091","https://openalex.org/W4238517656","https://openalex.org/W4244809572","https://openalex.org/W4298300172","https://openalex.org/W4324289996"],"related_works":["https://openalex.org/W1992469328","https://openalex.org/W127191188","https://openalex.org/W4210982479","https://openalex.org/W1983024776","https://openalex.org/W2411924610","https://openalex.org/W1587315543","https://openalex.org/W304941095","https://openalex.org/W2018016961","https://openalex.org/W2176159411","https://openalex.org/W2081458690"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Benzodiazepines,":[1],"either":[2],"alone":[3,81],"or":[4,212],"added":[5],"to":[6,38,106,119,216,224],"neuroleptics,":[7],"have":[8,132],"been":[9,23,134],"studied":[10],"extensively":[11],"as":[12,117],"treatments":[13],"for":[14],"schizophrenia,":[15],"but":[16,159],"no":[17],"consensus":[18],"regarding":[19],"their":[20,179],"efficacy":[21,180],"has":[22],"reached.":[24],"The":[25,45,72,93,167],"authors":[26,168],"review":[27,47],"the":[28,32,36,39,68,75,83,122,170,187,197,208,219,234,242],"double-blind":[29,50],"trials":[30],"in":[31,121,136,164,181,196,228,238],"literature":[33],"and":[34,63,66,82,103,151,183,241],"relate":[35],"findings":[37,73],"neurobiology":[40],"of":[41,60,70,78,86,108,125,143,173,189,199,210,236,245],"benzodiazepine":[42,174,225,232,246],"actions.":[43],"METHOD:":[44],"clinical":[46],"included":[48],"all":[49],"studies":[51,77,85,94],"through":[52],"1989":[53],"that":[54,97,205],"could":[55],"be":[56,146],"identified":[57],"by":[58,67],"means":[59],"Index":[61],"Medicus":[62],"computer-assisted":[64],"searches":[65],"cross-referencing":[69],"articles.":[71],"from":[74],"14":[76],"benzodiazepines":[79,112,144,195,237],"used":[80],"16":[84],"adjunctive":[87],"therapy":[88],"are":[89,113],"presented":[90],"separately.":[91],"RESULTS:":[92],"reviewed":[95],"suggest":[96],"1)":[98],"response":[99],"is":[100],"highly":[101],"variable,":[102],"about":[104],"one-third":[105],"one-half":[107],"patients":[109],"improve;":[110],"2)":[111],"potentially":[114],"most":[115,222],"useful":[116],"adjuncts":[118],"neuroleptics":[120],"acute":[123],"management":[124],"psychotic":[126],"agitation,":[127],"although":[128],"actual":[129],"antipsychotic":[130],"effects":[131],"also":[133],"observed":[135],"some":[137,165],"patients;":[138],"3)":[139],"relatively":[140],"higher":[141],"doses":[142],"may":[145,184],"associated":[147],"with":[148],"better":[149],"response;":[150],"4)":[152],"therapeutic":[153,217],"effects,":[154,218],"when":[155],"seen,":[156],"develop":[157],"rapidly":[158],"diminish":[160],"after":[161],"several":[162],"weeks":[163],"patients.":[166],"explore":[169],"neurobiological":[171],"bases":[172],"action,":[175],"which":[176],"presumably":[177],"underlie":[178],"schizophrenia":[182,200],"help":[185],"explain":[186],"variability":[188],"response.":[190],"CONCLUSIONS:":[191],"Future":[192],"research":[193],"on":[194,203],"treatment":[198],"should":[201],"focus":[202],"features":[204],"predict":[206],"response,":[207],"relation":[209],"dopamine":[211],"other":[213],"neurotransmitter":[214],"systems":[215],"schizophrenic":[220],"symptoms":[221],"amenable":[223],"treatment,":[226],"changes":[227],"neuroleptic":[229],"dose":[230],"during":[231],"augmentation,":[233],"role":[235],"maintenance":[239],"therapy,":[240],"optimal":[243],"characteristics":[244],"treatment.":[247]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W64322893","counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
